Annual Update

Service delivery across 120 sites: October 2018 - September 2019

• Provided HIV testing services to 1,043,912 people
• Identified 30,457 new people living with HIV (3.0% of those tested), and initiated 29,202 on treatment (95.8% of those diagnosed HIV-positive)
• Maintained an average of 199,586 ART clients on treatment throughout the 12-month period
• Of the 21,848 clients who received viral load test results, 86% were virally suppressed
•  A total of 104,282 HIV positive clients were transitioned to tenofovir/lamivudine/dolutegravir (TLD), this represents 57% of the adult cohort transitioned to TLD in line with WHO and Malawian National Government guidelines.
• Distributed 18,113 HIV self-test kits in four districts as part of the HIV self-testing strategy targeting men and you.

Latest publication
Read about the improved health outcomes from implementation of a program model employing HIV Diagnostic Assistants to enhance HIV service provision at health facilities across Malawi.
Access the article here

Holding a LPV/r pellets orientation with clinical providers at Kawale Health Center in Lilongwe, Malawi

Explaining how LPV/r pellets work at an orientation for lay health workers at Area 18 Health Center in Lilongwe, Malawi

Tingathe is growing its mission!
Tingathe has embarked on a process of refining its brand to ensure both internal and external stakeholders understand Tingathe's identity, including the vision and mission. Over the year we held events across the organization to spread the message and celebrate 10 years of Tingathe! 

Program updates

• Tingathe began distribution of HIV self-test kits as one of its active case identification approaches. The program distributed 2,726 self-test kits in Machinga and Mangochi districts from January to March 2019. See additional data on distribution in the graph below.
• Tingathe is supporting the Ministry of Health to transition adult ART clients to Dolutegravir-based treatment from January 2019. This support includes raising awareness, confirming adequate supplies, and providing switch guidelines and training to providers. A total of 77 providers from Mangochi and Salima districts were trained, and Tingathe mentors are providing one-on-one support for implementation.
• From January to March 2019, Tingathe focused its quality improvement efforts on increasing viral load coverage at supported sites. This included active screening, adjusting client flow, early morning sample collection, weekly mastercard audits, and close supervision and monitoring of data. This has resulted in a significant increase in coverage at most sites.
• Tingathe's cervical cancer program continues to grow: a total of 10,763 women living with HIV have been screened since services began in October 2018. Of these, 3,242 were women living with HIV. Of the 462 HIV+ clients found VIA+, 290 (63%) received same-day treatment. The remaining 172 women were either referred for various clinical reasons or refused treatment service.